Yojee Limited (ASX:YOJ)

Revance Therapeutics Revenue

Yojee had revenue of 338.87K AUD in the half year ending December 31, 2024, a decrease of -70.70%. This brings the company's revenue in the last twelve months to 787.52K, down -54.26% year-over-year. In the fiscal year ending June 30, 2024, Yojee had annual revenue of 1.02M, down -55.87%.

• Revenue (ttm): 787.52K
• Revenue Growth: -54.26%
• P/S Ratio: 201.57
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 158.74M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	1.02M	-1.29M	-55.87%
Jun 30, 2023	2.31M	240.33K	11.62%
Jun 30, 2022	2.07M	1.00M	94.48%
Jun 30, 2021	1.06M	409.35K	62.59%
Jun 30, 2020	654.07K	145.52K	28.61%